HTG Molecular Diagnostics Alpha and Beta Analysis
| HTGMDelisted Stock | USD 0.35 0.01 2.94% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as HTG Molecular Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in HTG Molecular over a specified time horizon. Remember, high HTG Molecular's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to HTG Molecular's market risk premium analysis include:
Beta (5.86) | Alpha (1.40) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
HTG |
HTG Molecular Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. HTG Molecular market risk premium is the additional return an investor will receive from holding HTG Molecular long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in HTG Molecular. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate HTG Molecular's performance over market.| α | -1.4 | β | -5.86 |
HTG Molecular Fundamentals Vs Peers
Comparing HTG Molecular's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze HTG Molecular's direct or indirect competition across all of the common fundamentals between HTG Molecular and the related equities. This way, we can detect undervalued stocks with similar characteristics as HTG Molecular or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of HTG Molecular's fundamental indicators could also be used in its relative valuation, which is a method of valuing HTG Molecular by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare HTG Molecular to competition |
| Fundamentals | HTG Molecular | Peer Average |
| Return On Equity | -3.43 | -0.31 |
| Return On Asset | -0.62 | -0.14 |
| Operating Margin | (3.15) % | (5.51) % |
| Current Valuation | 2.56 M | 16.62 B |
| Shares Outstanding | 2.21 M | 571.82 M |
| Shares Owned By Insiders | 6.54 % | 10.09 % |
| Shares Owned By Institutions | 0.74 % | 39.21 % |
HTG Molecular Opportunities
HTG Molecular Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | HTG Molecular Diagnostics Inc Faces Potential Delisting from ... - Best Stocks | 05/24/2023 |
2 | CancerTumour Profiling Market 2023, Emerging Growth Prospects ... - SleterFC.com | 05/30/2023 |
3 | HTG MOLECULAR DIAGNOSTICS, INC Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing - Marketscreener.com | 06/08/2023 |
4 | Tucson biotech firm HTG files for bankruptcy protection - Arizona Daily Star | 06/15/2023 |
5 | The molecular diagnostics market is valued at an estimated USD ... - GlobeNewswire | 07/12/2023 |
6 | Integra LifeSciences Q2 Earnings and Revenues Surpass ... - msnNOW | 07/26/2023 |
7 | Global CancerTumor Profiling Market Size and Forecast Qiagen ... - University City Review | 08/03/2023 |
About HTG Molecular Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including HTG or other delisted stocks. Alpha measures the amount that position in HTG Molecular Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
HTG Molecular Upcoming Company Events
As portrayed in its financial statements, the presentation of HTG Molecular's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HTG Molecular's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of HTG Molecular's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of HTG Molecular. Please utilize our Beneish M Score to check the likelihood of HTG Molecular's management manipulating its earnings.
| 10th of August 2023 Upcoming Quarterly Report | View | |
| 9th of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with HTG Molecular
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the HTG Molecular Diagnostics information on this page should be used as a complementary analysis to other HTG Molecular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in HTG Stock
If you are still planning to invest in HTG Molecular Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HTG Molecular's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |